SPECTRO FERRITIN

An Enzyme Immunoassay Procedure for the Quantitative Analysis of Serum Ferritin

Catalog Number:   S-22

 

SUMMARY

The serum ferritin concentration is proportional to the amount of iron in stores in the human body. The measurement of serum ferritin enables the clinician to differentiate between the anemia caused by iron deficiency and other forms of anemia1,2,3. Serum ferritin concentration is a useful, noninvasive screening test for iron overload, which may allow the detection of idiopathic hemochromatosis in the precirrhotic stages4.

 

TEST PRINCIPLE

The enzyme immunoassay for the quantitative determination of serum ferritin is basically a two stage reaction:

STAGE 1:   The binding of human serum ferritin to a solid phase antihuman ferritin, and the simultaneous binding of the purified antihuman ferritin conjugated with alkaline phosphatase to the insoluble immune-complex.

STAGE 2:    Reaction of alkaline phosphatase with a substrate solution consisting of phenylphosphate disodium and 4-amino-antipyrine. Following the addition of potassium ferricyanide a color develops, the optical density (490 - 510nm) of which is directly proportional to the ferritin concentration in the sample.

 

KIT CONTENTS

Prediluted Ferritin Calibrator Solutions:    6 vials containing 0.3ml human spleen ferritin calibrated to concentrations of 6, 20, 60, 200, 600, and 2000ng/ml, against WHO reference material (94/572), in phosphate buffered saline with rabbit serum and sodium azide as a preservative.   Store at 2 - 8C.   Do Not Use After Expiration Date on Vial.

Solid Phase Antihuman Ferritin:    96 microwells ("wells"), in the form of eight 1 X 12 strips, coated with rabbit antihuman spleen ferritin. Stored in a bottle containing borate buffer with bovine serum albumin, rabbit serum, and sodium chloride with sodium azide as a preservative.  Store at 2 - 8C.  Do Not Use After Expiration Date on Bottle.

Sample Diluting Buffer:    1 bottle containing 20 ml of phosphate buffered saline with rabbit serum and sodium azide as a preservative.  Store at 2 - 8C.  Do Not Use After Expiration Date on Bottle.

Conjugated Antihuman Ferritin:    1 bottle containing 23 ml of alkaline phosphatase conjugated rabbit antihuman spleen ferritin dissolved in 0.15 M phosphate buffered saline with 5% normal rabbit serum, and sodium azide as a preservative.  Store at 2 - 8C.  Do Not Use After Expiration Date on Bottle.

Substrate Solution:    1 bottle containing 23 ml of phenylphosphate disodium, 4-amino-antipyrine in 10% diethanolamine with sodium azide as a preservative.  Store at 2 - 8C.  Do Not Use After Expiration Date on Bottle.

Potassium Ferricyanide:    1 bottle containing 15 ml of potassium ferricyanide (0.24%) in water.  Store at 2 - 8C. Do Not Use After Expiration Date on Bottle.

Well Holder:    1 micro well holder.

Graph Paper:   1 sheet of Spectro Ferritin Standard Plot log-log graph paper.

 

 

PRECAUTIONS

This Kit is Intended for In-vitro Diagnostic Use Only

WARNING Reagents in this kit contain sodium azide. Contact with copper or lead drain pipes may result in the formation of explosive azide deposits. It is important during disposal to flush drains with copious amounts of water to prevent azide accumulation. Plumbing that may be contaminated with azides can be flushed with 10 percent sodium hydroxide solution.

 

Other Precautions:

  • Avoid splashing or generating aerosols.
  • Follow kit recommendations for incubation times and temperatures to avoid possibly erroneous results.
  • Microbial contamination of reagents may cause erroneous results.
  • Do not use reagents with those from other lots or manufacturers.
  • Do not use kit reagents after the expiration date.

 

SAMPLE COLLECTION AND PRESERVATION

Collect 5 ml of venous blood aseptically. Allow the blood to coagulate and separate the serum from the clot by centrifugation. Plasma may also be used for ferritin analysis. Moderate hemolysis will not interfere with the assay. If the assay will be performed within 7 days, store the serum refrigerated. If more than 7 days will elapse before the test is performed, the serum specimen should be frozen. Serum specimens may be stored frozen for 4 months without change in the ferritin content.

 

MATERIALS REQUIRED BUT NOT PROVIDED

  • Deionized or distilled water.
  • Precision pipettes capable of delivering volumes of 10, 100, and 200ul.
  • Microplate Reader capable of reading a red color at 500 ± 10nm (Optional: a background correction filter set at 600 to 650 nm).
  • Clinical rotator table or vibrator table. 

  

GENERAL INFORMATION ON PROCEDURE

The intensity of the color developed during the 2nd Stage incubation is directly proportional to both time and temperature; therefore, an increase in the 2nd Stage incubation time will increase the intensity of the color, while a decrease in the 2nd Stage incubation time will decrease the intensity of the color. The same applies for an increase or decrease in the incubation temperature.

 

 

ASSAY PROCEDURE

Determine the number of Solid Phase Antihuman Ferritin micro wells needed for the assay (each strip contains 12 wells) and remove any unnecessary wells before preceding with step 1. Replace any unused wells in the bottle of buffer and store at 2 - 8C.

Allow all reagents, sera, and patient samples to reach room temperature before performing assay.

1.   Remove the appropriate number of micro wells from the Solid Phase Antihuman Ferritin bottle, place in the Well Holder, and shake dry.

2.   Beginning with micro well C1 (skip wells A1 and B1), pipette 10ul of each Prediluted Ferritin Calibrator Solution and sample, in duplicate, into separate wells. Micro wells A1 and B1 measure non-specific binding (NSB) and will contain only the Conjugated Antihuman Ferritin.

3.   Pipette 200 ul of Conjugated Antihuman Ferritin into all micro wells.

4.   Incubate on a vibrator or clinical rotator table, set at 180 -200 rpm, for 2 hours at room temperature.

5.   Wash with deionized water by filling each micro well with water and shaking to decant. Repeat 3 times. After the final wash, tap the tops of the micro wells on absorbent material for about 30 seconds to drain.

6.   Pipette 200 ul of the Substrate Solution into each well.

7.   Incubate for 30 minutes at room temperature.

8.   Develop the color by adding 100ul of the 0.24% Potassium Ferricyanide to each micro well and mix thoroughly (eg 1 minute at 180 - 200 rpm).

9.   Zero the Microplate Reader with a blank prepared with 200 ul of the Substrate Solution and 100 ul of the Potassium Ferricyanide.

10.   Read the absorbance of all samples at 500 ± 10nm. If possible, use a correction wavelength of 600 -650nm and record the net values.

11.   If automatic background subtraction is not available, it is suggested that the plate be read a secong time at 600 - 650nm and these values be manually subtracted from the initial 500nm readings. Failure to compensate for the background absorbance may increase the variability of the assay and result in potentially erroneous values.

12.   Calculate the results. (See CALCULATIONS section below.)

 

SUMMARY OF ASSAY PROCEDURE

Procedural Flow Sheet - 1st Stage:

 

 

 

Microtiter                  Calibrator              Patient           Conjugated Anti-human                         Incubation      Tubes                           (ul)                   Sera (ul)                  Ferritin

A1 & B1                      **  (0 ng)                 --                          200

C1 & D1                     10  (6 ng)                 --                          200                                          INCUBATE

E1 & F1                     10  (20 ng)               --                          200                                           2 HOURS

G1 & H1                     10  (60 ng)              --                           200                                               ON A

A2 & B2                     10  (200 ng)                                         200                                           ROTATING

C2 & D2                     10  (600 ng)                                         200                                                OR

E2 & F2                     10   (2000 ng)                                      200                                           VIBRATING

G2 & H2                     --                           10                         200                                              TABLE

    etc.                        --                           10                         200

 

 

**The 0 ng/ml calibrator consists of the 200l Conjugated Antihuman Ferritin only and is used to measure nonspecific binding (NSB).

 

After the incubation period, wash each well with running deionized water, and shake to remove excess fluid.

 

Procedural Flow Sheet - 2nd Stage

 

 

Microtiter                              Substrate                          Incubation                  Tubes                                       (ul)

A1 & B1                                   200

C1 & D1                                   200                               INCUBATE

E1 & F1                                   200                              30 MINUTES

G1 & H1                                  200                                AT ROOM

A2 & B2                                  200                            TEMPERATURE

C2 & D2                                  200

E2 & F2                                  200

G2 & H2                                  200

   etc.                                      200

 

 

 

Add 100l of the 0.24% Potassium Ferricyanide to each microtiter tube and mix. Set the Microplate Reader to dual wavelengths of 500 ± 10 and 600 - 650nm. Zero the instrument using a blank made of 200 ul of Substrate Solution and 100 ul of the 0.24% Potassium Ferricyanide. Read and record the net absorbance of each Prediluted Ferritin Calibrator Solution, control, and patient sample. Readings should be taken within one hour of the completion of the assay.

 

For maximum precision, samples in excess of 1000 ng/ml should be diluted as follows:

1. Dilute the patient serum 1:10 with Sample Diluting Buffer.

2. Further dilutions may be made if necessary.

3. Re-assay these dilutions using the standard assay procedure and multiply the results by the dilution factor.

 

 

CALCULATIONS

Construct a calibration curve by plotting the net absorbance values obtained for each Prediluted Ferritin Calibrator Solution (mean O.D. of Calibrator minus NSB) on the vertical axis (Y) and the corresponding ferritin concentration in ng/ml on the horizontal axis (X) of the log-log Graph Paper. Draw a curve using a line drawn point to point. Calculate the average absorbance value for each control and patient sample. Determine the location of the average absorbance value on the Y-axis. Follow this point horizontally until it intersects the calibration curve. Follow this point of intersection with the curve vertically until it intersects the X-axis. This X-axis value will be the serum ferritin concentration of the control or patient sample.

Alternatively, the serum concentration of serum ferritin can be calculated using a logit log data reduction program. If you desire to use this form of calculation, call Ramco Laboratories at 800-231-6238 and we will help you develop the method best suited to your laboratory.

 

EXAMPLE DATA

(FOR DEMONSTRATION PURPOSES ONLY)

 

 

                                                                                                                                   CONC. ng/ml                        O.D.                        MEAN                       -NSB**                          ng/ml

                               0.007                                                                                                             0 or NSB**               0.010                        0.0085  

                               0.038                                                                                                             6                             0.037                        0.0375                        0.0295

                               0.100                                                                                                            20                           0.100                         0.1000                       0.0915

                               0.281                                                                                                           60                            0.246                        0.2635                       0.2550

                               0.700                                                                                                         200                          0.638                         0.669                        0.6605

                              1.259                                                                                                         600                         1.225                          1.242                        1.2335

                               1.772                                                                                                         2000                        1.757                         1.7645                        1.756

Sample 1                  0.385                                                                                                   (2403H)                     0.785                        0.810                          0.8015                                266

Sample 2                  0.285                                                                                                   (2402M)                    0.287                        0.286                           0.2775                                 65

Sample 3                   0.065                                                                                                   (2801L)                      0.059                       0.062                           0.0535                                 10

 

**0ng/ml calibrator measures nonspecific binding (NSB).

 

LIMITATIONS OF THE PROCEDURE

Moderate hemolysis has no effect upon the reproducibility or accuracy of the procedure. Iron administration causes the serum ferritin to increase. Anticoagulants have not been shown to influence the test so long as they do not result in dilution of the plasma. Strict adherence to precise laboratory procedure is essential for maximum accuracy of the final results.

 

EXPECTED VALUES

Normal values are age and sex dependent. Serum ferritin concentrations greater than 300 ng/ml may indicate increased iron stores as seen in idiopathic hemochromatosis.

The serum ferritin concentration reflects the amount of iron in stores. In iron deficiency, the stores are gone and the serum ferritin is very low (less than 20 ng/ml). In other kinds of anemia, iron stores are higher than normal and serum ferritin values are usually over 100 ng/ml. Values between 20 and 100 ng/ml in anemic patients may suggest a combination of iron deficiency with some cause of anemia. Serum ferritin concentrations greater than 300 ng/ml are elevated and may indicate increased iron stores as seen in idiopathic hemochromatosis.

 

PERFORMANCE CHARACTERISTICS

 

Intra-Assay Variability:  

SAMPLE # of RUNS MEAN ng/ml +/- 1 SD      C.V.  
1 8 10.4 0.60 5.8%
2 8 54.5 2.87 9.6%
3 8 208.0 9.69 4.7%

 

Inter-Assay Variability:  

SAMPLE # of RUNS MEAN ng/ml +/- 1 SD     C.V.  
1 12 11.0 0.74 6.8%
2 12 55.7 4.30 7.7%
3 12 219.0 9.20 8.7%

 

SENSITIVITY

Sensitivity is defined as the smallest value of ferritin which can be distinguished from the zero standard with a 95% confidence limit (± two standard deviations). Using the 10l sample size specified in the assay procedures, the smallest concentration of serum ferritin that can be distinguished from zero is 0.59 ng/ml.

 

BIBLIOGRAPHY

1. Addison, G.M.,Beamish, M.R.,Hales, C.N. et al: An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J. Clin. Pathol 25:326, 1972

2. Jacobs, A., Miller, F., Worwood, M., Beamish, M.R., Wardrop, C.A.: Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. British Medical Journal. 4:206, 1972

3. Lipschitz, David A., Cook, James D., and Finch, Clement A.: A clinical evaluation of serum ferritin as an index of iron stores. N. England J Med. 290:1213, 1974

4. Halliday, J.W., Cowlishaw, J.L., Russo, A.M., and Powell, L.W.: Serum ferritin in the diagnosis of haemochromotosis, Lancet, 621 September, 1977

5. Miles, L.E.M., Lipschitz, D.A.,Bieber, C.P., and Cook, J.D.: Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal. Chem. 61:209, 1974

6. Alfrey, C.P.: Serum Ferritin Assay. CRC Critical Reviews in Laboratory Sciences, 179, November 1978

7. Seiler, M., Alfrey, C., and Whitley, C.:Differentiation of iron deficiency from anemia of chronic disorders: The use of serum ferritin assay. Nuc Compact 9:160, 1978

8. Li, P. K., Humbert, J. R., and Cheng, C.: Evaluation of commercially obtainable ferritin test kit in relation to the high dose parabolic phenomenon, Clin. Chem. 24:1650, 1978

 

NOTICE

The Prediluted Ferritin Calibrator Solutions contained in this kit were calibrated against the 3rd International Standard for recombinant human ferritin established by the Expert Committee on Biological Standardization of the World Health Organization (coded 94/572).

The enclosed calibrators may give higher results than the calibrator solutions contained in previous kits (kit lot numbers < 3-063).

 

RAMCO LABORATORIES, INC.

4100 GREENBRIAR DR. STE. #200

STAFFORD, TEXAS 77477

800-231-6238

281-313-1200

 

Date Issued: 2/2/87. Revised: 5/29/87; 4/12/95; 11/11/98; 2/27/02; 4/27/06; 7/23/07; 01/12/09; 6/5/2014; 9/14/16